Cargando…
Bifidobacterium breve predicts the efficacy of anti‐PD‐1 immunotherapy combined with chemotherapy in Chinese NSCLC patients
BACKGROUND AND PURPOSE: Gut microbes play an important role in the occurrence of lung cancer, immunotherapy, and chemotherapy. In this study, we analyzed the characteristics of gut microbes in patients with lung cancer and investigated the effect of gut microbes on anti‐PD‐1 therapy combined with ch...
Autores principales: | Zhao, Honghui, Li, Dan, Liu, Jiayin, Zhou, Xinliang, Han, Jing, Wang, Long, Fan, Zhisong, Feng, Li, Zuo, Jing, Wang, Yudong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028067/ https://www.ncbi.nlm.nih.gov/pubmed/36205311 http://dx.doi.org/10.1002/cam4.5312 |
Ejemplares similares
-
Case Report: MSS colorectal extrahepatic (non-liver) metastases as the dominant population for immunotherapy combined with multi-target tyrosine kinase inhibitors
por: Liu, Jiayin, et al.
Publicado: (2023) -
Comparative genomics of the Bifidobacterium breve taxon
por: Bottacini, Francesca, et al.
Publicado: (2014) -
Immunomodulatory Effects of Bifidobacterium spp. and Use of Bifidobacterium breve and Bifidobacterium longum on Acute Diarrhea in Children
por: Choi, Yae Jin, et al.
Publicado: (2022) -
Genomic landscape and prognosis of patients with TP53-mutated non-small cell lung cancer
por: Fan, Zhisong, et al.
Publicado: (2022) -
Combined Lorlatinib, Dabrafenib, and Trametinib Treatment for ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer with a Lorlatinib-Induced BRAF V600E Mutation: A Case Report
por: Li, Dan, et al.
Publicado: (2022)